TP53 and colorectal carcinoma: (see Table S1); PDO5 WT and TP53 KO (generated by CRISPR-Cas9) (Fig. 1K, L) and the HCT116 (TP53 WT) and DLD1 CRC (TP53 mutated) cell lines (Fig. 1M).